This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
SANDOZ IRBESARTAN HCT
SANDOZ CANADA INCORPORATED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of SANDOZ IRBESARTAN HCT in Canada?
Yes. SANDOZ IRBESARTAN HCT 25MG 300MG has an active shortage reported to Health Canada (last updated September 14, 2026).
Why is SANDOZ IRBESARTAN HCT not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will SANDOZ IRBESARTAN HCT be available again?
The manufacturer's estimated resolution date is October 16, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02337444
Strength
25MG 300MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
HYDROCHLOROTHIAZIDE IRBESARTAN
Tier
Unrated
Last Updated
2026-08-24
Reason for Shortage
Shortage of an active ingredient.
Past Reports for This Drug
SANDOZ IRBESARTAN HCT has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495910
DIN 02495937
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759